Cargando…
Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
Hypoxia is characterized by an inadequate supply of oxygen to tissues, and hypoxic regions are commonly found in solid tumors. The cellular response to hypoxic conditions is mediated through the activation of hypoxia-inducible factors (HIFs) that control the expression of a large number of target ge...
Autores principales: | Taneja, Sakshi, Vetter, Stefan W., Leclerc, Estelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348933/ https://www.ncbi.nlm.nih.gov/pubmed/34360919 http://dx.doi.org/10.3390/ijms22158153 |
Ejemplares similares
-
The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010) -
RAGE Signaling in Melanoma Tumors
por: Olaoba, Olamide T., et al.
Publicado: (2020) -
Role of receptor for advanced glycation end products (RAGE) in liver disease
por: Yamagishi, Sho-ichi, et al.
Publicado: (2015) -
Leptin and advanced glycation end products receptor (RAGE) in tuberculosis patients
por: Lazzari, Tássia Kirchmann, et al.
Publicado: (2021) -
The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding
por: Indurthi, Venkata S.K., et al.
Publicado: (2020)